A Look At Spruce Point Capital’s Short Thesis On Ametek, Inc. (AME)
Earlier today (and as speculated by ValueWalk yesterday), Spruce Point Capital released its short thesis on manufacturing conglomerate Ametek, Inc. (NYSE:AME) claiming that the company manipulates its books in a variety of ways and that the stock has a downside of 30% - 50% (down about 3% at the moment, with plenty of volatility). The report is a monster, nearly . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible